Tampere University of Technology

TUTCRIS Research Portal

Pathways leading to suicide in schizophrenia

Research output: Contribution to journalReview ArticleScientificpeer-review

Standard

Pathways leading to suicide in schizophrenia. / Alaräisänen, Antti; Heikkinen, Johanna; Kianickova, Zuzana; Miettunen, Jouko; Räsänen, Pirkko; Isohanni, Matti.

In: Current Psychiatry Reviews, Vol. 3, No. 4, 01.11.2007, p. 233-242.

Research output: Contribution to journalReview ArticleScientificpeer-review

Harvard

Alaräisänen, A, Heikkinen, J, Kianickova, Z, Miettunen, J, Räsänen, P & Isohanni, M 2007, 'Pathways leading to suicide in schizophrenia', Current Psychiatry Reviews, vol. 3, no. 4, pp. 233-242. https://doi.org/10.2174/157340007782408879

APA

Alaräisänen, A., Heikkinen, J., Kianickova, Z., Miettunen, J., Räsänen, P., & Isohanni, M. (2007). Pathways leading to suicide in schizophrenia. Current Psychiatry Reviews, 3(4), 233-242. https://doi.org/10.2174/157340007782408879

Vancouver

Alaräisänen A, Heikkinen J, Kianickova Z, Miettunen J, Räsänen P, Isohanni M. Pathways leading to suicide in schizophrenia. Current Psychiatry Reviews. 2007 Nov 1;3(4):233-242. https://doi.org/10.2174/157340007782408879

Author

Alaräisänen, Antti ; Heikkinen, Johanna ; Kianickova, Zuzana ; Miettunen, Jouko ; Räsänen, Pirkko ; Isohanni, Matti. / Pathways leading to suicide in schizophrenia. In: Current Psychiatry Reviews. 2007 ; Vol. 3, No. 4. pp. 233-242.

Bibtex - Download

@article{84cb01d11e9b473ea5c067835cefcb40,
title = "Pathways leading to suicide in schizophrenia",
abstract = "The aim of this systematic review is to report the pre- and postmorbid trajectories leading to suicide in schizophrenia, with special focus on novel research published in 2003-2006. Individuals with schizophrenia who commit suicide seem to follow a developmental trajectory that differs partly from that of other schizophrenia patients. According to the studies analysed, there seem to be five main pathways for schizophrenia patients leading to suicide. One obvious pathway is comorbid depression that leads to suicide. Second, there is a group of patients with a difficult, chronic course of illness and many relapses and exacerbations. They lose their hope progressively over time. The third group comprises patients (mostly young males) with impulsiveness, dysphoric affect and substance abuse. Fourth, there is a relatively small but theoretically interesting and clinically important group of mainly young patients with high premorbid functioning and above average intellectual capacity. The high suicide rate among this group may be a consequence of their own and their relatives' high expectations that are in line with their good premorbid functioning. The fifth group, failure in treatment, comprises patients lacking social support whose treatment has failed. We also propose a life span model showing these five different pathways to suicide in schizophrenia. These suicidal trajectories could be useful in clinical work when evaluating patients' possible suicide risk and treating them. They might also provoke some further research ideas and hypotheses.",
keywords = "Developmental trajectory, Life-span, Schizophrenia, Suicide",
author = "Antti Alar{\"a}is{\"a}nen and Johanna Heikkinen and Zuzana Kianickova and Jouko Miettunen and Pirkko R{\"a}s{\"a}nen and Matti Isohanni",
note = "EXT={"}L{\"o}h{\"o}nen, Johanna{"}",
year = "2007",
month = "11",
day = "1",
doi = "10.2174/157340007782408879",
language = "English",
volume = "3",
pages = "233--242",
journal = "Current Psychiatry Reviews",
issn = "1573-4005",
number = "4",

}

RIS (suitable for import to EndNote) - Download

TY - JOUR

T1 - Pathways leading to suicide in schizophrenia

AU - Alaräisänen, Antti

AU - Heikkinen, Johanna

AU - Kianickova, Zuzana

AU - Miettunen, Jouko

AU - Räsänen, Pirkko

AU - Isohanni, Matti

N1 - EXT="Löhönen, Johanna"

PY - 2007/11/1

Y1 - 2007/11/1

N2 - The aim of this systematic review is to report the pre- and postmorbid trajectories leading to suicide in schizophrenia, with special focus on novel research published in 2003-2006. Individuals with schizophrenia who commit suicide seem to follow a developmental trajectory that differs partly from that of other schizophrenia patients. According to the studies analysed, there seem to be five main pathways for schizophrenia patients leading to suicide. One obvious pathway is comorbid depression that leads to suicide. Second, there is a group of patients with a difficult, chronic course of illness and many relapses and exacerbations. They lose their hope progressively over time. The third group comprises patients (mostly young males) with impulsiveness, dysphoric affect and substance abuse. Fourth, there is a relatively small but theoretically interesting and clinically important group of mainly young patients with high premorbid functioning and above average intellectual capacity. The high suicide rate among this group may be a consequence of their own and their relatives' high expectations that are in line with their good premorbid functioning. The fifth group, failure in treatment, comprises patients lacking social support whose treatment has failed. We also propose a life span model showing these five different pathways to suicide in schizophrenia. These suicidal trajectories could be useful in clinical work when evaluating patients' possible suicide risk and treating them. They might also provoke some further research ideas and hypotheses.

AB - The aim of this systematic review is to report the pre- and postmorbid trajectories leading to suicide in schizophrenia, with special focus on novel research published in 2003-2006. Individuals with schizophrenia who commit suicide seem to follow a developmental trajectory that differs partly from that of other schizophrenia patients. According to the studies analysed, there seem to be five main pathways for schizophrenia patients leading to suicide. One obvious pathway is comorbid depression that leads to suicide. Second, there is a group of patients with a difficult, chronic course of illness and many relapses and exacerbations. They lose their hope progressively over time. The third group comprises patients (mostly young males) with impulsiveness, dysphoric affect and substance abuse. Fourth, there is a relatively small but theoretically interesting and clinically important group of mainly young patients with high premorbid functioning and above average intellectual capacity. The high suicide rate among this group may be a consequence of their own and their relatives' high expectations that are in line with their good premorbid functioning. The fifth group, failure in treatment, comprises patients lacking social support whose treatment has failed. We also propose a life span model showing these five different pathways to suicide in schizophrenia. These suicidal trajectories could be useful in clinical work when evaluating patients' possible suicide risk and treating them. They might also provoke some further research ideas and hypotheses.

KW - Developmental trajectory

KW - Life-span

KW - Schizophrenia

KW - Suicide

U2 - 10.2174/157340007782408879

DO - 10.2174/157340007782408879

M3 - Review Article

VL - 3

SP - 233

EP - 242

JO - Current Psychiatry Reviews

JF - Current Psychiatry Reviews

SN - 1573-4005

IS - 4

ER -